Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia
NCT: NCT07658508 · ACTIVE_NOT_RECRUITING
Brief Summary
The goal of this clinical trial is to learn if calcipotriol and photodynamic therapy are equally effective in treatment of leukoplakia or not. The main questions it aims to answer are: do lesions decrease or disappear when treated by calcipotriol or PDT? does the drug affect the salivary biomarkers Participants will: Take calcipotriol daily for 4 weeks or perform 4 PDT sessions over 4 weeks measure changes in salivary biomarkers be followed up for 3 months
Frequently Asked Questions
What is Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia?
Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia is a clinical trial registered under NCT07658508. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07658508?
The current status of NCT07658508 (Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia) is: ACTIVE_NOT_RECRUITING.
When did Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia start?
Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia started on 2025-07-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.